The current stock price for Kairos Pharma Ltd (KAPA) is $0.94. The stock experienced a significant increase during the last trading session, reaching $12.0 after opening at $0.94. It dipped to a low of $4.0 before ultimately closing at $0.86.
Kairos Pharma Ltd’s stock has seen a rocky market performance.
52-week price history of KAPA Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Kairos Pharma Ltd’s current trading price is -76.50% away from its 52-week high, while its distance from the 52-week low is 135.00%. The stock’s price range for this period has remained between $0.40 and $4.00. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.96 million for the day, which was noticeably lower compared to the shares’ average daily volume of 5.12 million over the last three months.
Financial Performance and Market Capitalization
Kairos Pharma Ltd (KAPA) has experienced a quarterly rise of 15.85% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 15.84M and boasts a workforce of 4 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7965, with a change in price of -0.1000. Similarly, Kairos Pharma Ltd recorded 3,234,900 in trading volume during the last 100 days, posting a change of -9.62%.
KAPA Stock Stochastic Average
As of today, the raw stochastic average of Kairos Pharma Ltd over the last 50 days is at 38.03%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 25.74%. Further, the company’s Stochastic %K and %D values for the last 20 days were 21.63% and 22.32%, respectively.
KAPA Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors.
